Skip to main content
Log in

Histopathological evaluation of polymethyl methacrylate as an embolic agent

  • Clinical Articles
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Summary

Polymethyl methacrylate (PMMA) microspheres were used as an embolic agent to reduce the vascularity in eight patients with intracranial vascular tumours. Post embolization angiograms showed 30–60% reduction in the vascularity of the tumours. No patient developed any neurological complications in the immediate post-embolization period. These eight patients subsequently underwent surgery for the removal of their tumours. During surgery there was minimal blood loss and a good plane of cleavage was obtained between the tumour and the adjacent brain. The surgical specimens were examined histopathologically for the effects of PMMA. PMMA microspheres, in contrast to other cyano-acrylates — Isobutyl-2-cyano-acrylate (IBCA) — did not elicit either inflammatory reaction or mural angionecrosis within the wall of the embolised vessels. The histopathological studies suggest that PMMA microspheres are an inert material and can be used as an adjunct in the management of intracranial vascular tumours.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bernestein A, Kricheff I (1979) Catheter and material selection for transarterial embolization: technical consideration ii, Materials. Radiology 132: 631–639

    PubMed  Google Scholar 

  2. Debrun G, Vincula P, Fex A, Drake CG (1982) Embolization of arteriovenous malformation with bucrylate. Experience in 46 cases. J Neurosurg 56: 615–627

    PubMed  Google Scholar 

  3. Flandroy P, Grandfils C, Colligon J, Thibatute A, Nihant N, Barbette S, Jerome R, Teyssie PH (1990) (D.L) Polylactide microspheres as an embolic agent. A preliminary study. Neuroradiology 32: 311–315

    PubMed  Google Scholar 

  4. Jayakrishnan A, Thanoo BC, Ratinam K, Ravimandalam K, Rao VRK (1989) Hydrogel microspheres from cross-linked ethylene glycol dimethacrylate. Synthesis and biocompatibility studies. Bull Material Sciences 12: 17–25

    Google Scholar 

  5. Merrill EW, Pekala RW, Mahmud NA (1987) Hydrogel for blood contact. In: Pappas N (ed) Hydrogels in medicine and pharmacy, Vol 3. CRC Press, Florida, pp 1–16

    Google Scholar 

  6. Ratner BD, Hoffman AS (1976) Synthetic hydrogel for biomedical application for medical and related application. In: Andrage JD (ed). ACS Press, Washington, pp 1–35

    Google Scholar 

  7. Vinters HV, Lundie MJ, Kaufmann JCE (1986) Long term pathological follow-up of cerebral arteriovenous malformation treated by embolization with bucrylate. N Engl J Med 314: 477–487

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Radhakrishnan, V.V., Saraswathy, A., Rao, V.R.K. et al. Histopathological evaluation of polymethyl methacrylate as an embolic agent. Acta neurochir 117, 30–33 (1992). https://doi.org/10.1007/BF01400631

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01400631

Keywords

Navigation